100 related articles for article (PubMed ID: 7242310)
1. [Pharmacokinetics, effect and tolerance of isosorbide dinitrate and isosorbide-5-mononitrate in healthy persons].
Abshagen U; Spörl-Radun S; Betzien G; Kaufmann B; Endele R
Med Welt; 1981 Apr; 32(14A):508-16. PubMed ID: 7242310
[No Abstract] [Full Text] [Related]
2. [Isosorbide-5-mononitrate. A metabolite of isosorbide dinitrate].
Aldershvile J; Abildgaard U
Ugeskr Laeger; 1985 Jun; 147(24):1948-9. PubMed ID: 4024344
[No Abstract] [Full Text] [Related]
3. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
Smolarz A; Seeliger S; Glocke M
Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
[No Abstract] [Full Text] [Related]
4. Relationship between the pharmacodynamics and pharmacokinetics of two oral sustained-release formulations of isosorbide dinitrate in normal man.
Johnson KI; Gladigau V; Schnelle K
Arzneimittelforschung; 1981; 31(6):1026-9. PubMed ID: 7196234
[TBL] [Abstract][Full Text] [Related]
5. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
Geigenberger A; Degen J; Maier-Lenz H
Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
[TBL] [Abstract][Full Text] [Related]
6. Fate of isosorbide dinitrate and mononitrates in patients with renal failure.
Bogaert MG; Rosseel MT; Boelaert J; Daneels R
Eur J Clin Pharmacol; 1981; 21(1):73-6. PubMed ID: 7333349
[TBL] [Abstract][Full Text] [Related]
7. [Nitrite and methemoglobin formation in dogs following oral isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate].
Strein K; Dietmann K; Bartsch W
Med Welt; 1981 Apr; 32(14A):499-502. PubMed ID: 7242308
[No Abstract] [Full Text] [Related]
8. Pharmacokinetics and bioavailability of isosorbide-5-mononitrate in humans.
Rameis H; Bacher S; Eichler HG; Horwatitsch H
Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):678-80. PubMed ID: 4093207
[TBL] [Abstract][Full Text] [Related]
9. First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man.
Abshagen U; Spörl-Radun S
Eur J Clin Pharmacol; 1981; 19(6):423-9. PubMed ID: 7250175
[TBL] [Abstract][Full Text] [Related]
10. Newer aspects of the pharmacokinetics of organic nitrates.
Chasseaud LF
Z Kardiol; 1983; 72 Suppl 3():20-3. PubMed ID: 6666223
[TBL] [Abstract][Full Text] [Related]
11. Isosorbide 5-mononitrate pharmacokinetics in humans.
Taylor T; Chasseaud LF; Major R; Doyle E; Darragh A
Biopharm Drug Dispos; 1981; 2(3):255-63. PubMed ID: 7295882
[TBL] [Abstract][Full Text] [Related]
12. Influence of standard and nicotine-reduced cigarette smoke on plasma concentrations of isosorbide dinitrate and its metabolites in rats.
Gomita Y; Furuno K; Araki Y
J Pharm Pharmacol; 1991 Nov; 43(11):811-2. PubMed ID: 1686914
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of isosorbide dinitrate, isosorbide-5-mononitrate and sodium nitrite in isolated vascular preparations].
Heeg E; Langner A
Med Welt; 1981 Apr; 32(14A):497-8. PubMed ID: 7242307
[No Abstract] [Full Text] [Related]
14. [Pharmacokinetics of isosorbide-5-mononitrate in patients with advanced renal failure].
Kösters W; Klotschkoff P; Abshagen U
Med Welt; 1981 Apr; 32(14A):521-3. PubMed ID: 7242312
[No Abstract] [Full Text] [Related]
15. [Isosorbide mononitrate or dinitrate in coronary disease?].
Schanzenbächer P; Kochsiek K
Dtsch Med Wochenschr; 1983 May; 108(21):807-9. PubMed ID: 6851870
[No Abstract] [Full Text] [Related]
16. Inactivation of human aldehyde dehydrogenase by isosorbide dinitrate.
Mukerjee N; Pietruszko R
J Biol Chem; 1994 Aug; 269(34):21664-9. PubMed ID: 8063809
[TBL] [Abstract][Full Text] [Related]
17. Isosorbide 5-mononitrate pharmacokinetics.
Chasseaud LF
Cardiology; 1987; 74 Suppl 1():6-11. PubMed ID: 3300979
[TBL] [Abstract][Full Text] [Related]
18. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
Laufen H; Aumann M; Leitold M
Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
Reifart N; Reifart F; Kaltenbach M; Bussmann WD
Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
[No Abstract] [Full Text] [Related]
20. [Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease].
Mannebach H; Ohlmeier H; von Möllendorff E; Gleichmann U; Abshagen U
Med Welt; 1981 Apr; 32(14A):517-20. PubMed ID: 7242311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
